Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 468-472

  Haskó, György ^a   Szabó, Csaba ^a,b   Németh, Zoltán H ^a   Salzman, Andrew L ^b   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cyclic AMP; Cytokine; IFN ; Lipopolysaccharide; TNF

Indexed keywords

AMRINONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; ENDOTOXEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; AMRINONE; ANIMALS; ENDOTOXEMIA; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PYRROLIDINONES; ROLIPRAM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031914563     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<468::AID-IMMU468>3.0.CO;2-Z     Document Type: Article

References (15)

1. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995. 13: 251-276.
2. Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P. and Trinchieri, G., Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 1995. 25: 672-676.
3. Berg, D. J., Kühn, R., Rajewsky, K., Müller, W., Menon, S., Davidson, N., Grünig, G. and Rennick, D., Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 1995. 96: 2339-2347.
4. Pastores, S. M., Hasko, G., Vizi, E. S. and Kvetan, V., The role of vasoactive drugs in the regulation of cytokine production in sepsis. New Horiz. 1996. 4: 252-264.
5. Le Tulzo, Y., Shenkar, R., Kaneko, D., Moine, P., Fantuzzi, G., Dinarello, C. A. and Abraham, E., Hemorrhage increases cytokine expression in lung mononuclear cells in mice. J. Clin. Invest. 1997. 99: 1516-1524.
6. Sinha, B., Semmler, J., Eisenhut, T., Eigler, A. and Endres, S., Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 1995. 25: 147-153.
7. Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V., Pastores, S. M. and Vizi, E. S., Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 1996. 157: 4634-4640.
8. Szabó, C., Haskó, G., Zingarelli, B., Németh, Z. H., Salzman, A. L., Kvetan, V., McCarthy Pastores, S. and Vizi, E. S., Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeacitivity in endotoxemia. Immunology 1997. 90: 95-100.
9. van der Pouw Kraan, T. C. T. M., Boeije, L. C. M., Smeenk, R. J. T., Wijdenes, J. and Aarden, L. A., Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 1995. 181: 775-779.
10. Kambayashi, T., Jacob, C. O., Zhou, D., Mazurek, N., Fong, M. and Strassmann, G., Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 1995. 155: 4909-4916.
11. Németh, Z. H., Haskó, G., Szabó, C. and Vizi, E. S., Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 1997. 7: 371-375.
12. Giroir, B. P. and Beutler, B., Effect of amrinone on tumor necrosis factor production in endotoxic shock. Circ. Shock 1992. 36: 200-207.
13. Sekut, L., Yarnall, D., Stimpson, S. A., Noel, L. S., Bateman-Fite, R., Clarks, R. L., Brackeen, M. F., Menius, J. A. JR and Conolly, K. M., Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin. Exp. Immunol. 1995. 100: 126-132.
14. Sommer, N., Löschmann, P.-A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmüller, A., Fontana, A., Dichgans, J. and Martin, R., The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1995. 1: 244-248.
15. Jilg, S., Barsig, J., Leist, M., Küsters, S., Volk, H.-D. and Wendel, A., Enhanced release of interleukin-10 and soluble tumor necrosis factor receptors as novel principles of methylxanthine action in murine models of endotoxic shock. J. Pharmacol. Exp. Ther. 1996. 278: 421-431.